Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Hip Osteoarthritis
Interventions: Not listed
Lead sponsor: Anne Arundel Health System Research Institute; Other
Eligibility: 40 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Annapolis, Maryland

Conditions: Hip Osteoarthritis, Knee Osteoarthritis
Interventions: Shared Decision Making Intervention; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Redwood City, California • San Francisco, California

Conditions: Arthropathy of Hip
Interventions: Vecuronium 0.1 mg/kg, Vecuronium 0.2mg/kg; Drug
Lead sponsor: Craig Curry; Other
Eligibility: 50 Years to 75 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Osteoarthritis
Interventions: Anterior Approach, Posterior Approach; Procedure
Lead sponsor: Medacta USA; Industry
Eligibility: 40 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 4
States / cities: Surprise, Arizona • Fresno, California • Lone Tree, Colorado + 1 more

Conditions: Osteoarthritis, Osteo Arthritis Knee, Osteo Arthritis Shoulders, Osteoarthritis of Multiple Joints, Osteoarthritis, Hip, Osteoarthritis - Ankle/Foot
Interventions: Tissue Stromal Vascular Fraction (tSVF) Arm 1, PRP Concentrate Arm 1, Tissue Stromal Vascular Fraction (tSVF) Arm 2, PRP Concentrate Arm 2, Cellular Stromal Vascular Fraction (cSVF) Arm 2, Cellular Stromal Vascular Fraction (cSVF) Arm 3, Sterile Normal Saline (IV Solution); Procedure · Biological · Drug
Lead sponsor: Healeon Medical Inc; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Valencia, California • Stevensville, Montana

Conditions: Arthropathy, Hip Arthropathy, Hip Osteoarthritis
Interventions: Restoration Anatomic Acetabular Shell; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2036
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Osteoarthritis of the Hip
Interventions: Not listed
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Developmental Dysplasia of Hip
Interventions: Duration of Pavlik Harness treatment, 12 week standard of care; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 0 Weeks to 18 Weeks
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Osteoarthritis, Pain
Interventions: Placebo, Fulranumab 1 mg, Fulranumab 3 mg; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 26
States / cities: Phoenix, Arizona • Costa Mesa, California • Laguna Hills, California + 23 more

Conditions: Osteoarthritis, Hip, Joint Deformities, Acquired, Hip Dislocation, Congenital, Osteonecrosis, Arthritis, Rheumatoid
Interventions: Aquamantys, standard electrocautery (Bovie); Device
Lead sponsor: Joint Implant Surgeons, Inc.; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New Albany, Ohio

Conditions: Osteoarthritis, Hip, Osteoarthritis, Knee, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases
Interventions: CR845 tablet 1 mg, CR845 tablet 2.5 mg, CR845 tablet 5 mg, Placebo tablet; Drug
Lead sponsor: Cara Therapeutics, Inc.; Industry
Eligibility: 25 Years and older
Enrollment: 761 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 35
States / cities: Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 29 more

Conditions: Leg Length Inequality, Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Shoe lift correction for leg length inequality; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 55 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Smithfield, North Carolina

Conditions: Chronic Low Back Pain, Hip Ostearthritis, Myofascial Pain Syndrome, Fibromyalgia, Depression, Maladaptive Coping, Lumbar Spinal Stenosis, Insomnia, Sacroiliac Joint Pain, Lateral Hip and Thigh Pain, Anxiety, Dementia, Recent Leg Length Discrepancy
Interventions: Patient-Centered Care, Imaging-Directed Care; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years to 89 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Richmond, Virginia

Conditions: Osteoarthritis of the Hip
Interventions: MONOVISC, Saline; Device
Lead sponsor: DePuy Mitek; Industry
Eligibility: 30 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 27
States / cities: Tucson, Arizona • Encinitas, California • Rancho Mirage, California + 21 more

Conditions: Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect, Bone Marrow Aspirate Concentrate
Interventions: Bone marrow aspirate concentrate (BMAC), Control; Biological · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2045
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoarthritis, Vitamin D Deficiency
Interventions: Vitamin D3; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 96 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Non-inflammatory Degenerative Joint Disease
Interventions: 36 mm ceramic head on a ceramic acetabular liner, 28 mm ceramic head on a polyethylene acetabular liner; Device
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 5
States / cities: Sacramento, California • Denver, Colorado • Winston-Salem, North Carolina + 2 more

Conditions: Hip Osteoarthritis
Interventions: Lumbar plexus block, Quadratus lumborum type 3 block, Ropivacaine injection; Procedure · Drug
Lead sponsor: Sharad Khetarpal; Other
Eligibility: 18 Years to 90 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Overweight, Obesity, Physical Inactivity, Weight Loss
Interventions: OA CARE Intervention, Usual Care control group; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Osteoarthritis, Hip, Musculoskeletal Diseases
Interventions: Synvisc (hylan G-F 20); Device
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 35 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 32
States / cities: Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 29 more

Conditions: Osteoarthritis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years and older
Enrollment: 1,950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 5
States / cities: Glenview, Illinois • Woodbury, Minnesota • Syracuse, New York + 2 more

Conditions: Osteoarthritis
Interventions: tanezumab 10 mg, tanezumab 5 mg, oxycodone, placebo; Biological · Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 66
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 54 more

Conditions: Osteoarthritis, Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis
Interventions: Trilogy AB Acetabular Hip Implant System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Fort Lauderdale, Florida • Philadelphia, Pennsylvania

Conditions: Osteoarthritis of Hip, Traumatic Arthritis of Hip
Interventions: Total Hip Arthroplasty; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 75 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Hip Replacement in a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost

Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee

Does Deep Neuromuscular Blockade Improve Operating Conditions During Total Hip Replacements?

Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty

Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis

Restoration Anatomic Acetabular Shell Revision Study

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Should Graf IIc Hips be Treated for 12 Weeks

Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002

Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty

A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee

Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms

Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)

The MONOVISC Hip Osteoarthritis Study

Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)

36 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement

Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

OA Clinic-Community CARE Model

A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Massachusetts General Hospital Evaluation of DePuy ASR Hip System

Tanezumab In Osteoarthritis Of The Hip Or Knee

Trilogy AB Acetabular Hip System Post Approval Study

Long-Term Multi-center Evaluation of E-Poly and Regenerex